Related Experiment Videos
Mycobacterial infections in Norway
1Department of Infectious Diseases, Ullevål Hospital, Oslo, Norway.
Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1995
Summary
Norway has seen a decline in tuberculosis and leprosy cases. However, atypical mycobacteria infections are rising, posing a growing public health challenge, particularly in immunocompromised individuals.
Area of Science:
- Medical Microbiology
- Infectious Diseases Epidemiology
Background:
- Tuberculosis (TB) incidence in Norway has dramatically declined since the 1930s.
- Leprosy cases are now rare in Norway, with imported cases presenting diagnostic challenges.
- Emerging infections from atypical mycobacteria are a growing concern.
Purpose of the Study:
- To review the epidemiological trends of tuberculosis and leprosy in Norway.
- To highlight the increasing challenge posed by atypical mycobacteria infections.
- To discuss current therapeutic approaches and emerging public health issues in mycobacterial diseases.
Main Methods:
- Retrospective analysis of epidemiological data for tuberculosis and leprosy in Norway.
- Review of current treatment protocols for leprosy, including multidrug therapy.
- Assessment of trends in infections caused by atypical mycobacteria, including Mycobacterium avium-intracellulare complex.
Main Results:
- While TB incidence has decreased, a plateau in notified cases has occurred in the last decade.
- Drug-resistant tuberculosis strains have not been a significant issue.
- Atypical mycobacteria infections, notably Mycobacterium avium-intracellulare complex in AIDS patients, are increasing.
Conclusions:
- Norway has successfully controlled tuberculosis and leprosy historically, but challenges remain.
- The rise of atypical mycobacteria necessitates ongoing surveillance and adapted management strategies.
- Public health initiatives must address the evolving landscape of mycobacterial infections, including those in vulnerable populations.